Advertisement

Topics

PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument

00:53 EDT 11 Jul 2019 | News-Medical.net

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and anti-EBV/EBNA (Epstein-Barr Virus) antibodies on its EUROIMMUN RA Analyzer 10 system.

Original Article: PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument

NEXT ARTICLE

More From BioPortfolio on "PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...